Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
Omeros' COVID-19 Opportunity And Challenges
02:53pm, Monday, 17'th Aug 2020
Omeros' old story, with its heavy reliance on OMIDRIA revenues, is drifting away. Omeros' initial success in treating COVID-19 presents intriguing possibilities.
Here's Why Omeros Fell Over 13% Today
04:35pm, Wednesday, 12'th Aug 2020
Shares of Omeros (NASDAQ: OMER) fell as much as 13.3% today after the company announced the pricing of a public offering of common stock and more details about a debt offering. The biopharma will of
Omeros Announces Pricing of Public Offerings
10:30am, Wednesday, 12'th Aug 2020
Omeros Corporation (Nasdaq: OMER) ("Omeros") today announced that it has priced concurrent underwritten public offerings of 6,900,000 of shares of its common stock (the "Shares") at a public offering
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) * Allovir Inc (NASDAQ: ALVR) * BioLife Solutions Inc (NASDAQ: BLFS) * BioSpecifics Technologies Corp. (NASDAQ: BSTC) (reacted to sec
Omeros (OMER) Reports Q2 Loss, Lags Revenue Estimates
09:45pm, Monday, 10'th Aug 2020
Omeros (OMER) delivered earnings and revenue surprises of 11.11% and -25.33%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Omeros : Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes | MarketScreener
08:13pm, Monday, 10'th Aug 2020Omeros Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
08:12pm, Monday, 10'th Aug 2020
Omeros Corporation (Nasdaq: OMER) ("Omeros") today announced that it has commenced concurrent underwritten public offerings of $125,000,000 of shares of its common stock (the "Shares") and $200,000,00
Omeros Corporation Reports Second Quarter 2020 Financial Results
08:01pm, Monday, 10'th Aug 2020
Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as wel
Dow Jones Leads, Nasdaq Lags As Market Weighs Trump Orders, China Tensions
04:25pm, Monday, 10'th Aug 2020
The Dow Jones Industrial Average hit new session highs midday while the Nasdaq lagged, amid heightened U.S.-China tensions.
Omeros Rallies On COVID-19 Study Results: What You Should Know
03:41pm, Monday, 10'th Aug 2020
Omeros Corporation (NASDAQ: OMER) shares were galloping higher Monday after the biopharma announced results from a compassionate use study of its lead investigational human monoclonal antibody.What Ha
ROCE Insights For Omeros
03:35pm, Monday, 10'th Aug 2020
Omeros (NASDAQ: OMER) reported Q1 sales of $23.54 million. Earnings fell to a loss of $23.68 million, resulting in a 0.12% decrease from last quarter. Omeros collected $33.42 million in revenue during
Omeros Reports Coronavirus Treatment Success; Stock Soars
01:01pm, Monday, 10'th Aug 2020
Small Omeros on Monday reported success with a test of its corononavirus treatment, saying it helped the recovery of six patients severely ill with Covid-19.
Omeros Corporation (Nasdaq: OMER) today reported the results of a compassionate-use study evaluating narsoplimab, Omeros’ investigational human monoclonal antibody targeting mannan-binding lectin-as
Omeros Corporation (Nasdaq: OMER) today reported the results of a compassionate-use study evaluating narsoplimab, Omeros’ investigational human monocl
Analysts Estimate Omeros (OMER) to Report a Decline in Earnings: What to Look Out for
04:30pm, Thursday, 06'th Aug 2020
Omeros (OMER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
